Literature DB >> 17804806

Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7.

Frederic Sierro1, Christine Biben, Laura Martínez-Muñoz, Mario Mellado, Richard M Ransohoff, Meizhang Li, Blanche Woehl, Helen Leung, Joanna Groom, Marcel Batten, Richard P Harvey, Carlos Martínez-A, Charles R Mackay, Fabienne Mackay.   

Abstract

Chemotactic cytokines (chemokines) attract immune cells, although their original evolutionary role may relate more closely with embryonic development. We noted differential expression of the chemokine receptor CXCR7 (RDC-1) on marginal zone B cells, a cell type associated with autoimmune diseases. We generated Cxcr7(-/-) mice but found that CXCR7 deficiency had little effect on B cell composition. However, most Cxcr7(-/-) mice died at birth with ventricular septal defects and semilunar heart valve malformation. Conditional deletion of Cxcr7 in endothelium, using Tie2-Cre transgenic mice, recapitulated this phenotype. Gene profiling of Cxcr7(-/-) heart valve leaflets revealed a defect in the expression of factors essential for valve formation, vessel protection, or endothelial cell growth and survival. We confirmed that the principal chemokine ligand for CXCR7 was CXCL12/SDF-1, which also binds CXCR4. CXCL12 did not induce signaling through CXCR7; however, CXCR7 formed functional heterodimers with CXCR4 and enhanced CXCL12-induced signaling. Our results reveal a specialized role for CXCR7 in endothelial biology and valve development and highlight the distinct developmental role of evolutionary conserved chemokine receptors such as CXCR7 and CXCR4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804806      PMCID: PMC1976222          DOI: 10.1073/pnas.0702229104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase.

Authors:  T C Lee; Y D Zhao; D W Courtman; D J Stewart
Journal:  Circulation       Date:  2000-05-23       Impact factor: 29.690

Review 2.  Dancing to the tune of chemokines.

Authors:  M Thelen
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

Review 3.  Chemokines: immunology's high impact factors.

Authors:  C R Mackay
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

4.  Chemokine receptor homo- or heterodimerization activates distinct signaling pathways.

Authors:  M Mellado; J M Rodríguez-Frade; A J Vila-Coro; S Fernández; A Martín de Ana; D R Jones; J L Torán; C Martínez-A
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

5.  Guidance of primordial germ cell migration by the chemokine SDF-1.

Authors:  Maria Doitsidou; Michal Reichman-Fried; Jürg Stebler; Marion Köprunner; Julia Dörries; Dirk Meyer; Camila V Esguerra; TinChung Leung; Erez Raz
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

6.  A role for smad6 in development and homeostasis of the cardiovascular system.

Authors:  K M Galvin; M J Donovan; C A Lynch; R I Meyer; R J Paul; J N Lorenz; V Fairchild-Huntress; K L Dixon; J H Dunmore; M A Gimbrone; D Falb; D Huszar
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

7.  Fusion of RDC1 with HMGA2 in lipomas as the result of chromosome aberrations involving 2q35-37 and 12q13-15.

Authors:  Karin Broberg; Miao Zhang; Bodil Strömbeck; Margareth Isaksson; Malin Nilsson; Fredrik Mertens; Nils Mandahl; Ioannis Panagopoulos
Journal:  Int J Oncol       Date:  2002-08       Impact factor: 5.650

Review 8.  The Marfan syndrome.

Authors:  R E Pyeritz
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

9.  Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow.

Authors:  P A Koni; S K Joshi; U A Temann; D Olson; L Burkly; R A Flavell
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

10.  The chemokine SDF1 regulates migration of dentate granule cells.

Authors:  Anil Bagri; Theresa Gurney; Xiaoping He; Yong-Rui Zou; Dan R Littman; Marc Tessier-Lavigne; Samuel J Pleasure
Journal:  Development       Date:  2002-09       Impact factor: 6.868

View more
  252 in total

1.  The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12.

Authors:  Hongsheng Wang; Natalie Beaty; Sophia Chen; Chen-Feng Qi; Marek Masiuk; Dong-Mi Shin; Herbert C Morse
Journal:  Blood       Date:  2011-11-22       Impact factor: 22.113

Review 2.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

Review 3.  Regulation of neutrophil trafficking from the bone marrow.

Authors:  Ryan B Day; Daniel C Link
Journal:  Cell Mol Life Sci       Date:  2011-11-02       Impact factor: 9.261

Review 4.  CXCL12 in control of neuroinflammation.

Authors:  Miljana Momcilović; Marija Mostarica-Stojković; Djordje Miljković
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 5.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

6.  The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.

Authors:  Stéphanie Gravel; Camille Malouf; Philip E Boulais; Yamina A Berchiche; Shinya Oishi; Nobutaka Fujii; Richard Leduc; Daniel Sinnett; Nikolaus Heveker
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

7.  Carboxy-terminus of CXCR7 regulates receptor localization and function.

Authors:  Paramita Ray; Laura Anne Mihalko; Nathaniel L Coggins; Pranav Moudgil; Anna Ehrlich; Kathryn E Luker; Gary D Luker
Journal:  Int J Biochem Cell Biol       Date:  2012-01-25       Impact factor: 5.085

8.  Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.

Authors:  Joshua J Ziarek; Anthony E Getschman; Stephen J Butler; Deni Taleski; Bryan Stephens; Irina Kufareva; Tracy M Handel; Richard J Payne; Brian F Volkman
Journal:  ACS Chem Biol       Date:  2013-06-26       Impact factor: 5.100

9.  Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity.

Authors:  Elnaz Menhaji-Klotz; Jessica Ward; Janice A Brown; Paula M Loria; Carina Tan; Kevin D Hesp; Keith A Riccardi; John Litchfield; Markus Boehm
Journal:  ACS Med Chem Lett       Date:  2020-05-14       Impact factor: 4.345

10.  Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.

Authors:  Patricia Rueda; Adèle Richart; Alice Récalde; Pamela Gasse; José Vilar; Coralie Guérin; Hugues Lortat-Jacob; Paulo Vieira; Franoise Baleux; Fabrice Chretien; Fernando Arenzana-Seisdedos; Jean-Sébastien Silvestre
Journal:  Circulation       Date:  2012-10-03       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.